全文获取类型
收费全文 | 1175篇 |
免费 | 1篇 |
国内免费 | 1篇 |
专业分类
耳鼻咽喉 | 4篇 |
儿科学 | 109篇 |
妇产科学 | 32篇 |
基础医学 | 126篇 |
口腔科学 | 29篇 |
临床医学 | 35篇 |
内科学 | 344篇 |
皮肤病学 | 23篇 |
神经病学 | 78篇 |
特种医学 | 28篇 |
外科学 | 234篇 |
预防医学 | 30篇 |
眼科学 | 36篇 |
药学 | 39篇 |
肿瘤学 | 30篇 |
出版年
2023年 | 2篇 |
2022年 | 1篇 |
2021年 | 12篇 |
2019年 | 113篇 |
2018年 | 125篇 |
2017年 | 59篇 |
2016年 | 2篇 |
2015年 | 2篇 |
2013年 | 3篇 |
2011年 | 2篇 |
2008年 | 2篇 |
2007年 | 1篇 |
2002年 | 1篇 |
2001年 | 2篇 |
2000年 | 2篇 |
1999年 | 3篇 |
1997年 | 1篇 |
1995年 | 1篇 |
1985年 | 58篇 |
1984年 | 88篇 |
1983年 | 61篇 |
1982年 | 78篇 |
1981年 | 94篇 |
1980年 | 84篇 |
1979年 | 77篇 |
1978年 | 72篇 |
1977年 | 54篇 |
1976年 | 54篇 |
1975年 | 42篇 |
1974年 | 39篇 |
1973年 | 41篇 |
1972年 | 1篇 |
排序方式: 共有1177条查询结果,搜索用时 22 毫秒
1.
Joseph F. Levy Rahul Khairnar Alexander V. Louie Timothy N. Showalter C. Daniel Mullins Mark V. Mishra 《Practical radiation oncology》2019,9(2):e172-e179
Purpose
A hydrogel rectal spacer (HRS) is a medical device that is approved by the U.S. Food and Drug Administration to increase the separation between the prostate and rectum. We conducted a cost-effectiveness analysis of HRS use for reduction in radiation therapy (RT) toxicities in patients with prostate cancer (PC) undergoing external beam RT (EBRT).Methods and Materials
A multistate Markov model was constructed from the U.S. payer perspective to examine the cost-effectiveness of HRS in men with localized PC receiving EBRT (EBRT alone vs EBRT + HRS). The subgroups analyzed included site of HRS placement (hospital outpatient, physician office, ambulatory surgery center) and proportion of patients with good baseline erectile function (EF). Data on EF, gastrointestinal and genitourinary toxicities incidence, and potential risks associated with HRS implantation were obtained from a recently published randomized clinical trial. Health utilities and costs were derived from the literature and the 2018 Physician Fee Schedule and were discounted 3% annually. Quality-adjusted life years (QALYs) and costs were modeled for a 5-year period from receipt of RT. Probabilistic sensitivity analysis and value-based threshold analyses were conducted.Results
The per-patient 5-year incremental cost for spacers administered in a hospital outpatient setting was $3578, and the incremental effectiveness was 0.0371 QALYs. The incremental cost-effectiveness ratio was $96,440/QALY for patients with PC undergoing HRS insertion in a hospital and $39,286/QALY for patients undergoing HRS insertion in an ambulatory facility. For men with good baseline EF, the incremental cost-effectiveness ratio was $35,548/QALY and $9627/QALY in hospital outpatient and ambulatory facility settings, respectively.Conclusions
Based on the current Medicare Physician Fee Schedule, HRS is cost-effective at a willingness to pay threshold of $100,000. These results contain substantial uncertainty, suggesting more evidence is needed to refine future decision-making. 相似文献2.
Genetics of human immune response to allergens 总被引:3,自引:0,他引:3
3.
Two patients with chronic myelogenous leukemia and new variant Philadelphia chromosome translocations are reported. In one case, a 41-year-old male, a 10;22 translocation was found in all bone marrow cells examined. Furthermore, the Y chromosome was missing in 90% of the analyzed metaphase cells. In the second patient, a 22-year-old male, all the marrow cells contained a complex rearrangement involving chromosomes No. 2, 9, and 22. 相似文献
4.
Body temperature is elevated in the early postmortem period 总被引:1,自引:0,他引:1
G M Hutchins 《Human pathology》1985,16(6):560-561
During the collection of specimens at autopsy for biochemical analysis, it was observed that body temperatures were higher than expected. To evaluate this observation further, rectal temperatures were determined at the earliest feasible time after death in 20 adult patients for whom recent premortem rectal temperatures were available for comparison. The average premortem temperature was 37.6 degrees C (range, 34.9 to 41.1 degrees C) and had been obtained 19 to 240 minutes (average, 107 minutes) before death. The average postmortem temperature, also 37.6 degrees C (range, 35.5 to 41.3 degrees C), was obtained 116 to 401 minutes (average, 202 minutes) after death. In the 11 patients in whom the postmortem interval was less than three hours (average, 155 minutes), there was an average postmortem temperature increase of 0.5 degree C (range, +1.3 to -0.7 degree C). The results suggest that there is usually an initial postmortem elevation in body temperature as measured rectally, probably as a result of continuing tissue and bacterial metabolism in the absence of the usual heat-dispersal mechanisms. This phenomenon should be considered when postmortem materials are used for analysis or when postmortem interval is determined by body temperature. 相似文献
5.
6.
7.
8.
To explore the possible influence of multiple myeloma on age-related amyloid accumulation, the frequency, extent and distribution of amyloid deposition in 35 patients who died of multiple myeloma was compared to that observed in 138 patients of comparable age but without myeloma (controls). The presence of multiple myeloma did not appear to enhance the development of age-related amyloid.Amyloid deposition in the patients with myeloma could be distinguished from that in the patients without myeloma by the occasional finding of amyloid in the bone marrow. In addition, material having the tinctorial and ultrastructural characteristics of amyloid was found in the renal tubular casts of 15 patients with myeloma but in none of the controls.The results suggest that although the appearance of amyloid in certain locations appears to be characteristic of multiple myeloma, the presence of amyloid in the heart or vascular system, even in considerable amounts, in a patient with multiple myeloma does not necessarily imply that the two conditions are related. 相似文献
9.